ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 2.500
0.00 (0.00%)
Aug 7, 2026, 9:30 AM EST
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 75.97 million as of August 10, 2026. Its market cap has decreased by -60.50% in one year.
Market Cap
75.97M
Enterprise Value
75.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.50
ChartMarket Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 75.97M, an increase of 426.44%. That is a compound annual growth rate of 80.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 75.97M | -36.79% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 122.20M |
| Eastwood Bio-Medical Canada | 93.00M |
| NurExone Biologic | 46.06M |
| Onco-Innovations | 44.40M |
| BriaCell Therapeutics | 44.11M |
| Sernova Biotherapeutics | 43.43M |
| MedMira | 42.10M |
| Microbix Biosystems | 39.95M |